TLR3 Activation of Intratumoral CD103(+) Dendritic Cells Modifies the Tumor Infiltrate Conferring Anti-tumor Immunity

An important challenge in cancer immunotherapy is to expand the number of patients that benefit from immune checkpoint inhibitors (CI), a fact that has been related to the pre-existence of an efficient anti-tumor immune response. Different strategies are being proposed to promote tumor immunity and...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Immunol
Autori principali: Roselli, Emiliano, Araya, Paula, Núñez, Nicolás Gonzalo, Gatti, Gerardo, Graziano, Francesca, Sedlik, Christine, Benaroch, Philippe, Piaggio, Eliane, Maccioni, Mariana
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2019
Soggetti:
Immunology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6435583/
https://ncbi.nlm.nih.gov/pubmed/30949170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.00503
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi